Molina Healthcare (MOH) Given Coverage Optimism Score of 0.04
Media coverage about Molina Healthcare (NYSE:MOH) has trended somewhat positive recently, according to Accern. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Molina Healthcare earned a news impact score of 0.04 on Accern’s scale. Accern also gave media headlines about the company an impact score of 46.668259123756 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the news stories that may have effected Accern’s analysis:
- Molina Healthcare, Inc. (MOH) Director Sells $18,042.50 in Stock (americanbankingnews.com)
- Uber starts offering rides to the doctor (finance.yahoo.com)
- Ascend Capital LLC Boosts Holdings in Molina Healthcare, Inc. (MOH) (americanbankingnews.com)
- Steven J. Orlando Sells 1,500 Shares of Molina Healthcare, Inc. (MOH) Stock (americanbankingnews.com)
- Molina Healthcare, Inc. (MOH) Stake Lifted by Swiss National Bank (americanbankingnews.com)
A number of equities analysts recently commented on MOH shares. Jefferies Group upped their target price on Molina Healthcare from $64.00 to $74.00 and gave the company a “hold” rating in a report on Friday, November 3rd. Morgan Stanley upped their target price on Molina Healthcare from $68.00 to $89.00 and gave the company an “overweight” rating in a report on Friday, November 3rd. Zacks Investment Research upgraded Molina Healthcare from a “sell” rating to a “hold” rating in a report on Monday, November 6th. ValuEngine raised Molina Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, November 9th. Finally, Raymond James Financial reaffirmed a “hold” rating on shares of Molina Healthcare in a research note on Friday, December 8th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $73.73.
In other news, Director Charles Z. Fedak sold 4,487 shares of the stock in a transaction on Thursday, February 15th. The stock was sold at an average price of $72.55, for a total value of $325,531.85. Following the sale, the director now directly owns 20,648 shares of the company’s stock, valued at $1,498,012.40. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Terry Bayer sold 2,804 shares of the stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $91.63, for a total value of $256,930.52. Following the completion of the sale, the chief operating officer now directly owns 70,092 shares in the company, valued at $6,422,529.96. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 733,265 shares of company stock worth $57,969,788. 6.20% of the stock is owned by insiders.
COPYRIGHT VIOLATION WARNING: “Molina Healthcare (MOH) Given Coverage Optimism Score of 0.04” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://www.watchlistnews.com/molina-healthcare-moh-given-coverage-optimism-score-of-0-04/1903270.html.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.